Doxercalciferol Injection Vials
Sandoz announces the US launch of doxercalciferol injection, the first generic version of Genzyme’s Hectorol. Doxercalciferol injection is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease who are on dialysis. The product is being marketed in 4 mcg/2 mL–single-use vials. The recommended initial dose of doxercalciferol injection is 4 mcg administered intravenously as a bolus 3 times weekly at the end of dialysis.
Single-use vials: 4 mcg/2 mL
For More Information: www.us.sandoz.com
Rabeprazole Sodium Delayed-Release Tablets
Kremers Urban Pharmaceuticals Inc
Aciphex Delayed-Release tablets (Eisai Inc)
Kremers Urban Pharmaceuticals Inc announces the release of rabeprazole sodium delayed-release tablets, a generic equivalent of Eisai Inc’s Aciphex. It is a proton pump inhibitor indicated for the healing of erosive or ulcerative gastroesophageal reflux disease (GERD), maintenance of healing of erosive or ulcerative GERD, treatment of symptomatic GERD, healing of duodenal ulcers, Helicobacter pylori eradication to prevent duodenal ulcers, and treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.
Tablets: 20 mg
For More Information: www.kremersurban.com
Telmisartan and Amlodipine Tablets
Torrent Pharmaceuticals Limited
Twynsta (Boehringer Ingelheim)
Torrent Pharmaceuticals Limited has released telmisartan and amlodipine tablets, a generic equivalent to Twynsta. It is an angiotensin II–receptor blocker and a dihydropyridine calcium channel blocker indicated for the treatment of hypertension alone or in conjunction with other antihypertensive agents. It can be substituted for its individually titrated components, and may also be given with increased amounts of amlodipine, telmisartan, or both, as needed.
Tablets (telmisartan/amlodipine): 40 mg/5 mg; 40 mg/10 mg; 80 mg/5 mg; 80 mg/10 mg
For More Information: www.torrentpharma.com/int_usa.php
Aldara Cream (Medicis Pharmaceutical Corporation)
Teva Pharmaceuticals announces the introduction and availability of imiquimod cream. The product is AB rated and bioequivalent to Aldara cream, manufactured by Medicis Pharmaceutical Corporation. It is indicated for the treatment of actinic keratosis and external genital warts. Imiquimod cream should be applied to the affected areas 2 times per week for 16 weeks for actinic keratosis, and 3 times per week to external genital or perianal warts.
Single-use packets of topical cream: 250 mg
For More Information: www.tevagenerics.com